Nxera Receives $10 Mln Milestone Payment From AbbVie
TOKYO (dpa-AFX) - Nxera Pharma Co., Ltd. (SOLTF) on Tuesday said it received a $10 million milestone payment from AbbVie (ABBV) after achieving a fourth R&D milestone under their multi-target drug discovery collaboration focused on neurological diseases.The companies partnered in 2022 to discover G…